Whole Genome Sequencing

This is a test that looks at the entire genetic code (DNA) of your body. It's like getting a complete map of your genes, which can help doctors understand your health and potential risks.

Procedure

What people who've had Whole Genome Sequencing report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Whole Genome Sequencing

Who It's For

Whole genome sequencing is a genetic test that reads nearly all of a person's DNA, the set of instructions that guides how the body grows and works. A laboratory determines the order of the DNA building blocks and compares it with reference sequences to look for changes, called variants, that could explain a health problem. It differs from exome sequencing, which reads only the protein-coding parts of genes (about 1 percent of the genome). Because genome sequencing also covers the stretches between and around genes, it can detect some disease-causing changes that exome sequencing misses. The test is mainly used to look for the cause of a suspected genetic condition when the answer is not obvious. The American College of Medical Genetics and Genomics recommends that exome or genome sequencing be considered as a first- or second-tier test for children with birth differences (congenital anomalies), developmental delay or intellectual disability, rather than only after many narrower tests. Rapid genome sequencing is also used for critically ill newborns and infants, where a quick diagnosis can shape care. Adults with an unexplained rare disease are sometimes tested too. A smaller test is often the better choice. When symptoms point to one condition or a short list of genes, a targeted gene panel or single-gene test may answer the question with fewer uncertain results. Genome sequencing in clinical care is not a general screening test for healthy people, and it is different from direct-to-consumer DNA kits and from tumor sequencing, which examines cancer tissue to guide cancer treatment.

Before the Procedure

Testing usually starts with a visit to a medical geneticist or genetic counselor, who reviews the person's symptoms, medical records, earlier test results and family history. That history matters: the lab uses it to decide which variants are likely to be relevant. Genetic counseling before and after the test is recommended so people understand the possible results and their limits. The consent discussion covers several choices. One is whether to receive secondary findings: variants unrelated to the reason for testing that point to a serious, treatable condition, such as an inherited risk of certain cancers or heart rhythm disorders. Laboratories report these from a list of genes maintained by the medical genetics society, and people can choose to opt out. Consent also covers whether results or samples may be used for research, and how results could affect relatives. When a child is tested, the clinic often asks both biological parents to give samples as well (called trio testing). Comparing the child's DNA with the parents' helps the lab tell whether a variant is new or inherited, and testing the patient alone is associated with a lower chance of finding a diagnosis. Costs and insurance coverage vary, so it helps to ask about both before the sample is sent. No fasting or other physical preparation is usually needed.

During the Procedure

For the person being tested, the procedure is simply a sample collection. Most often this is a standard blood draw from the arm; some tests use saliva or a cheek swab, and newborns usually give a small blood sample. It takes minutes, needs no sedation or anesthesia, and people can go about their day immediately. The real work happens in the laboratory. Technicians extract DNA, break it into fragments and read them on sequencing machines, then software reassembles the readings and lists the person's variants. Because everyone carries millions of harmless differences, specialists filter and interpret them against the person's symptoms and medical databases, which is why results take time. Genome sequencing can also be done before birth on a sample from amniocentesis or chorionic villus sampling, but that sampling is a separate procedure with its own risks.

Recovery & Aftercare

There is no recovery period beyond a possible small bruise where blood was drawn. The main thing that follows is the wait for results, which depends on the lab and the purpose of testing. Rapid testing for a critically ill infant is set up to return results much faster, while routine testing commonly takes weeks. Results are usually discussed in a follow-up visit with the genetics team. A positive result means a variant that likely explains the condition was found. This can end a long search for an answer, guide treatment or monitoring, connect a family with others who have the same condition, and inform family planning. A negative result means no explanatory variant was identified; it does not rule out a genetic cause, because some changes are hard to detect or not yet linked to disease. An uncertain result, called a variant of uncertain significance, is a change that might or might not matter. It cannot confirm or rule out a diagnosis by itself; testing relatives or re-testing later may clarify it. Any secondary finding is usually confirmed and followed by advice on screening or preventive care. Because relatives share DNA, a meaningful result may lead the care team to suggest testing for family members.

Risks & Complications

The physical risk is minimal, limited to the usual minor effects of a blood draw. The more important trade-offs are about information. Most people tested do not get a diagnosis. In studies of critically ill infants and of children with developmental disorders, genome sequencing found a genetic cause in roughly 30 to 40 percent; the chance depends on the condition and is generally lower when symptoms begin in adulthood or when parents are not tested. Uncertain variants are common and can cause worry or lead to extra testing. Secondary findings can reveal an unexpected risk, bringing benefits from early care alongside stress and follow-up costs. Results can also carry emotional weight for the whole family because results can reveal information about blood relatives as well as the person tested. In the US, the Genetic Information Nondiscrimination Act (GINA) prevents health insurers and most employers from using genetic information against a person. It does not cover life insurance, disability insurance or long-term care insurance, and it does not apply to employers with fewer than 15 employees or the military. Some states add protections. People thinking about those kinds of insurance may want to consider this timing before testing.

Questions to Ask Your Doctor

  1. 1.Would genome sequencing, exome sequencing or a smaller gene panel best answer the question in my situation, and why?
  2. 2.Should my parents or other relatives give samples too, and how would that change the chance of a diagnosis?
  3. 3.Which secondary findings could be reported, and what would happen if I chose to opt out?
  4. 4.If the result is negative or uncertain, what are the next steps, and can my data be reviewed again later?
  5. 5.What will my insurance cover, and how long will results take?

Last reviewed • Oct 2026

Educational content, not medical advice.